Integrative Pathway-Level Survival Analysis in Breast Cancer Using ssGSEA and FDR-Corrected Cox Modeling of TCGA Cohorts
CSEF · 2026 Computational Science (Senior Division)
Overview
Breast cancer’s molecular complexity presents significant challenges in identifying robust and reproducible prognostic biomarkers. This study applies an integrative, pathway-level survival modeling framework to The Cancer Genome Atlas (TCGA) breast cancer cohort to uncover survival-associated biological processes using transcriptomic data. Individual patient pathway activities were quantified using single-sample Gene Set Enrichment Analysis (ssGSEA), enabling a sample-specific assessment of coordinated pathway dysregulation. These enrichment scores were evaluated for association with overall survival using univariate Cox proportional hazards regression, with multiple hypothesis testing controlled via the Benjamini–Hochberg false discovery rate (FDR). Four pathways remained statistically significant following FDR correction (FDR < 0.05). HALLMARK_PROTEIN_SECRETION (HR = 1.56, p = 0.000858, FDR = 0.015), HALLMARK_HYPOXIA (HR = 1.54, p = 0.000898, FDR = 0.015), and HALLMARK_UV_RESPONSE_DN (HR = 1.44, p = 0.000790, FDR = 0.015) emerged as the strongest adverse prognostic features. HALLMARK_TGF_BETA_SIGNALING (HR = 1.45, p = 0.002032, FDR = 0.025) also demonstrated a significant association with survival. These hazard ratios indicate that increased activation of specific biological programs is associated with elevated mortality risk per standard deviation increase in pathway activity. This work demonstrates that pathway-level modeling integrating ssGSEA with FDR-corrected Cox regression can identify biologically meaningful survival signals that may be obscured in gene-level analyses. By providing a scalable and reproducible computational framework for pathway prioritization, this study supports the application of systems-level transcriptomic modeling to inform prognostic research and precision oncology strategies in breast cancer.
Competition history
- CSEF 2026
Related projects
ISEF · 2025
Spatial Tumor-Immune Analysis: Insights From Pathology Slides and Breast Cancer Survival
ISEF · 2020
Modeling Distant Metastasis-Free Survival: Applications to Hazard Prediction and Pairwise Gene Interaction Discovery
CSEF · 2015
A Systems Biology Approach to Optimize Prediction of Efficacy of Pathway Targeted Therapies in Cancer
ISEF · 2022
A Novel Computational Pipeline To Identify Target Genes That Define Cancer Subtypes To Improve Cancer Detection and Therapy
CSEF · 2013
Breast Cancer Prognosis through Gene Expression Profiling and Tumor Morphology
ISEF · 2026
TMEInsight: Elucidating Patient-Specific Immune-Pathway Crosstalk via Deep Learning to Foreshadow Tumor Progression
ISEF · 2015
A Computer-Based Integrated Analysis of Genomic Signatures in Ovarian Cancer
ISEF · 2025
Multi-omics Predictive Model for Personalized Breast Cancer Prognosis
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects